Skip to content

Clinical trials

Completed Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Status: Completed Clear all

387 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200021
200114
200215
200314
200425
200527
200615
200724
200824
20099
201024
201119
201218
201312
20148
201514
201610
201711
20185
20196
20202
20213
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed387

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center39
Fred Hutchinson Cancer Center32
National Cancer Institute (NCI)23
Memorial Sloan Kettering Cancer Center14
Mayo Clinic13
National Heart, Lung, and Blood Institute (NHLBI)11
Alliance for Clinical Trials in Oncology10
German CLL Study Group9
H. Lee Moffitt Cancer Center and Research Institute8
Hoffmann-La Roche8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell387
Leukemia153
Lymphoma, Non-Hodgkin148
Lymphoma, Follicular147
Lymphoma, B-Cell, Marginal Zone135
Precursor Cell Lymphoblastic Leukemia-Lymphoma128
Lymphoma, Mantle-Cell125
Lymphoma124
Lymphoma, Large B-Cell, Diffuse113
Hodgkin Disease108

Trials

Showing 1 to 25 of 387. Each trial links to its page on Pharma Observatory.

287 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.